MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 21, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC)...
TEL AVIV, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of...
SciSparc Achieves Milestone with Patient Dosed in Autism Spectrum Disorder Trial
SciSparc: MitoCareX Reveals Promising Results
SciSparc Announces Enrollment of First Patient for Clinical Trial for Children
SciSparc Issued Patent for Opioids Reduction Use in Pain Management Technology